Comments on “Treatment of diabetic neuropathy with γ-linolenic acid” by The γ-Linolenic Multicenter Trial Group

Wolever, Thomas M S

doi:10.2337/diacare.16.9.1309a

Article navigation

Letters| September 01 1993

Comments on “Treatment of diabetic neuropathy with γ-linolenic acid” by The γ-Linolenic Multicenter Trial Group

Thomas M S Wolever, MD, PHD

Clinical Nutrition and Risk Factor Modification Center, Division of Endocrinology and Metabolism, St. Michael's Hospital

Toronto, Ontario, Canada

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Thomas Wolever, md, phd, St. Michael's Hospital, Division of Endocrinology and Metabolism, 30 Bond Street, Toronto, Ontario, Canada, M5B 1W8.

Diabetes Care 1993;16(9):1309

https://doi.org/10.2337/diacare.16.9.1309a

PubMed:

8404440

Comments on “Treatment of diabetic neuropathy with γ-linolenic acid” by The γ-Linolenic Multicenter Trial Group

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Comments on “Treatment of diabetic neuropathy with γ-linolenic acid” by The γ-Linolenic Multicenter Trial Group

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only